Related Experiment Video
Updated: Sep 18, 2025
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Early versus delayed catheter ablation in atrial fibrillation and heart failure: A systematic review and
Mustafa Eray Kilic1, Mehmet Emin Arayici2, Yigit Resit Yilancioglu3
1Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, Izmir, Türkiye.
Insights
Early catheter ablation (CA) for atrial fibrillation (AF) and heart failure (HF) significantly reduces AF recurrence and HF hospitalizations. A mortality benefit was not statistically confirmed, warranting cautious interpretation.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) and heart failure (HF) frequently coexist, leading to poorer patient outcomes.
- Catheter ablation (CA) is a recognized treatment, but its optimal timing in conjunction with HF is not well-defined.
Purpose of the Study:
- To evaluate the clinical outcomes of early versus delayed catheter ablation in patients diagnosed with both AF and HF.
- To assess the impact of ablation timing on AF recurrence, heart failure hospitalizations, and all-cause mortality.
Main Methods:
- A systematic review and meta-analysis of comparative studies involving adult patients with AF and HF.
- Studies were registered (CRD42025643686) and followed PRISMA guidelines.
- Primary outcomes included AF recurrence, HF hospitalizations, and all-cause mortality, analyzed using random-effects meta-analyses.
Main Results:
- Ten studies (15,822 patients) indicated early CA significantly reduced AF recurrence (HR 0.63) and HF hospitalizations (HR 0.63).
- A trend towards reduced all-cause mortality was observed but did not reach statistical significance (HR 0.71).
- Heterogeneity varied across outcomes, being absent for HF hospitalization, moderate for AF recurrence, and high for mortality.
Conclusions:
- Pooled data from observational studies suggest early CA benefits patients with AF and HF by reducing AF recurrence and HF hospitalizations.
- A statistically confirmed mortality benefit was not identified.
- Caution is advised due to reliance on observational data and heterogeneity among included studies.
Background:
Atrial fibrillation (AF) and heart failure (HF) frequently coexist, worsening outcomes. Catheter ablation (CA) is an established therapy, but the optimal timing remains unclear.
Objective:
This study aimed to evaluate the impact of early vs delayed CA on clinical outcomes in patients with AF and HF.
Methods:
This International Prospective Register of Systematic Reviews-registered systematic review (CRD42025643686) adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Comparative studies enrolling adults with AF and HF were included. Early CA was defined as ablation performed within varying timeframes (often ≤12 months) after AF diagnosis or HF decompensation vs delayed CA beyond that period. Primary outcomes were AF recurrence, all-cause mortality, and HF hospitalizations. Random-effects meta-analyses were performed.
Results:
Ten studies (n = 15,822) contributed to the meta-analyses. Early CA was associated with significantly reduced AF recurrence (k = 8, hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.52-0.78, P < .0001) and HF hospitalization (k = 5, HR 0.63, 95% CI 0.51-0.77, P < .0001). A nonsignificant trend toward reduced all-cause mortality was observed (k = 4, HR 0.71, 95% CI 0.41-1.24, P = .23). Statistical heterogeneity was absent for HF hospitalization (I2 = 0%), moderate for AF recurrence (I2 = 67.6%), and high for mortality (I2 = 75.3%). Narrative synthesis included 2 additional randomized controlled trials comparing treatment strategies.
Conclusion:
Evidence from pooled observational studies suggests early CA is associated with reduced AF recurrence and HF hospitalization in patients with AF and HF; a mortality benefit was not statistically confirmed. Interpretation warrants caution owing to reliance on observational data and methodological heterogeneity across studies.
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System